To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the covid-19 outbreak on the number of patients receiving treatment for Kawasaki disease in (a) Wales and (b) the UK.
23 November 2020
The Department only holds data for activity in England as health is a devolved matter. The Department, alongside NHS England, continues to consider the impact of COVID-19 on patients with Kawasaki disease and other rare diseases.
NHS England has had discussions with some services and patients/patient groups to understand the impact of COVID-19. NHS England has worked with commissioned providers, patient groups and charities throughout the pandemic to ensure that patients, carers and their families have been supported during the COVID-19 outbreak and ensuring those discussions inform planning for autumn and winter.